Results 151 to 160 of about 26,689 (268)

Donor Blood Management: A Complementary Framework to Patient Blood Management

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Blood donation is a generous act that saves lives. However, the journey of the donated blood from collection to patient benefit is complex, and donor value may be reduced or lost through collection and processing losses, inventory wastage, expiry, handling errors, inappropriate clinical utilisation and incidents. Patient Blood Management (PBM)
Allameddine Allameddine, Andrea Piccin
wiley   +1 more source

Peripheral blasts at apheresis as a risk factor for survival after tisagenlecleucel in children and young adults. [PDF]

Blood Adv
Lyons KU, Miller KR, Deb A, Nicklawsky A, Baggott C, Nguyen K, Prabhu S, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano JA, Moskop A, Keating AK, Baumeister S, Myers GD, Karras NA, Cooper S, Qayed M, Hermiston M, Satwani P, Krupski C, Chinnabhandar V, Mackall CL, John S, Laetsch TW, Curran KJ, Verneris MR, Schultz LM, Fabrizio VA.   +29 more
europepmc   +1 more source

Predicting Non-Target Neutrophil Collection During HPC(A): Implications for Research Protocols in Apheresis. [PDF]

J Clin Apher
Castillo-Aleman YM, Villegas-Valverde CA, Ventura-Carmenate Y, Lumame S, Rose-Roque JM, Cato M, Ali H, Ali RM, Hernandez-Corrales R, Sarode A, Zuñiga-Rosales Y, Marsan-Suarez V, Bencomo-Hernandez AA.   +12 more
europepmc   +1 more source

Real-world outcomes for multiple myeloma patients after apheresis for planned chimeric antigen receptor T-cell therapy. [PDF]

World J Exp Med
Bangolo A, Gill S, Zhang L, Zhao J, Amoozgar B, Reich-Slotky R, Tran J, Vo T, Mariblanca G, Balulescu X, Mcknight S, Patel N, Reed A, Kaur S, Subramanian S, Katyal J, Manikkuttiyil C, Chakov M, Nguyen A, Pashine S, Khalil A, Mathew S, Gill R, Andrews V, Ordonez P, Olson B, Koleng M, Persaud R, Saride HS, Dharsi M, Thach R, Chen W, Shahid M, Weissman S, Siegel D, Parmar H, Biran N, Vesole DH, Phull P.   +38 more
europepmc   +1 more source

Chronic Thromboembolic Pulmonary Hypertension With Cold Agglutinins Needing Pulmonary Thromboendarterectomy: The Use of Therapeutic Plasma Exchange

Pulmonary Circulation, Volume 16, Issue 4, October 2026.
ABSTRACT Cold agglutinins can be detected in patients with chronic thromboembolic pulmonary hypertension (CTEPH) during pulmonary thromboendarterectomy (PTE) pre‐operative testing. Peri‐operative management of these patients in anticipation of deep hypothermic circulatory arrest can be challenging and has not been standardized. We describe our relevant
Beenish Naqvi, Marie A. Bautista, Amber P. Sanchez, Jenny Z. Yang, Timothy M. Fernandes, David S. Poch, Kim M. Kerr, Nick H. Kim, Michael M. Madani, Victor G. Pretorius, Elizabeth S. Allen, Patricia M. Kopko, Laura D. Dilly, Charles Ginsberg, Soo J. Park, Michael Choi, Dinna N. Cruz, Demosthenes G. Papamatheakis   +17 more
wiley   +1 more source

Real-World Outcomes of Lipoprotein Apheresis in Homozygous Familial Hypercholesterolemia: A Single-Center Longitudinal Experience. [PDF]

J Clin Med
Mercan Sarıdaş F, Ersoy C, Özkalemkaş F, Hocaoğlu E, Yaşar M, Karatoprak K, Öz Gül Ö, Cander S, Ertürk E.   +8 more
europepmc   +1 more source

Transfusion medicine, apheresis, and hemostasis : review questions and case studies /

Includes index.Vendor-supplied metadata.Cover -- Title page -- Copyright page -- Dedication -- Contents -- Contributors -- About the Editors -- Preface -- Acknowledgment -- Laboratory Reference Ranges -- Chapter 1 -- Pretest -- Answers and brief ...
Pham, Huy P.,editor., Williams, Lance A.III,editor.   +1 more
core  

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies

British Journal of Haematology, Volume 209, Issue 4, Page 1469-1481, October 2026.
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi, Nandakumar Natarajan, Kathryn E. Dickerson, Richard A. Voit   +3 more
wiley   +1 more source

Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia

, 2014
Lipoprotein-apheresis (apheresis) removes LDL-cholesterol in patients with severe dyslipidemia. However, reduction is transient, indicating that the long-term cardiovascular benefits of apheresis may not solely be due to LDL removal. Microparticles (MPs)
D Aled Rees (10871627), Irina A. Guschina (60160), David A. Price (1788990), Dev B. N. Datta (12315345), Gareth R. Willis (10650821), Philip James (10871836), Katherine D. Connolly (12302145), Elizabeth A. Ellins (7243850), Kristin Ladell (122980)   +8 more
core  

Adjusted delivery, stronger outcomes: Selinexor therapeutic adaptation and positioning in previously treated multiple myeloma

British Journal of Haematology, Volume 209, Issue 4, Page 1970-1973, October 2026.
In patients with lenalidomide‐refractory multiple myeloma from the BOSTON trial subgroup analysis,1 selinexor (SEL) dose reduction versus full dosing substantially improved efficacy outcomes, including higher overall response rate (74.3% vs. 55.6%), deeper responses (≥ very good partial response: 48.6% vs.
Muhamed Baljevic
wiley   +1 more source